Clinical Evaluation of Enteral-extended Anti-reflux Stents for Pancreatic Pseudocyst

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

At present, endoscopic therapy is the preferred method to solve biliary or pancreatic diseases. And EUS-guided stent implantation and drainage of pancreatic pseudocyst is the main method in Endoscopic treatment of pancreatic pseudocyst. However, blockage of stent is a problem that has puzzled endoscopists for a long time. The mechanism of stent blockage is related to the reflux of gastrointestinal contents into the stent. Although plastic stents are widely used in patients who needed drainage. However, the average free time for stent is only 77 to 126 days, leading to the need for stent replacement in most patients within 3 months. As one end of the double pigtail stent used for drainage of pancreatic pseudocyst may be located in the stomach, it may cause the stent to be blocked by the contents of the stomach. Therefore, multiple stents or additional stents or drainage tube are often needed to further strengthen the drainage.

It seems that the mechanism of stent blockage are associated with gastrointestinal contents reflux. And stents required be replaced again by endoscopic approach when jamming. However, EUS and ERCP are difficult, costly, and may be with complications. Additional operations will increase the risks and costs. Therefore, a stent that can effectively prevent reflux, solve clinical problems, and effectively prolong stent patency time is urgently needed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Intraintestinal Extended Biliary Stents Preventing Duodenobiliary Reflux in Patients With Biliary Stricture

NCT04550819

Bile Duct Stricture

UNKNOWN NA

Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents

NCT01585662

Pancreatic Pseudocyst

UNKNOWN PHASE4

Endoscopic Ultrasound-guided Drainage of Pancreatic Pseudocysts

NCT03022110

Pancreatic Pseudocyst

UNKNOWN NA

A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct

NCT05523778

Insulinoma

RECRUITING NA

Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis

NCT02594891

Cholangitis Complication

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At present, endoscopic therapy is the preferred method to solve biliary or pancreatic diseases. And EUS-guided stent implantation and drainage of pancreatic pseudocyst is the main method in Endoscopic treatment of pancreatic pseudocyst. However, blockage of stent is a problem that has puzzled endoscopists for a long time. The mechanism of stent blockage is related to the reflux of gastrointestinal contents into the stent. Although plastic stents are widely used in patients who needed drainage. However, the average free time for stent is only 77 to 126 days, leading to the need for stent replacement in most patients within 3 months. As one end of the double pigtail stent used for drainage of pancreatic pseudocyst may be located in the stomach, it may cause the stent to be blocked by the contents of the stomach. Therefore, multiple stents or additional stents or drainage tube are often needed to further strengthen the drainage.

It seems that the mechanism of stent blockage are associated with gastrointestinal contents reflux. And stents required be replaced again by endoscopic approach when jamming. However, EUS and ERCP are difficult, costly, and may be with complications. Additional operations will increase the risks and costs. Therefore, a stent that can effectively prevent reflux, solve clinical problems, and effectively prolong stent patency time is urgently needed.

The extended enteral anti-reflux stent developed by our research team has potential advantages in prolonging the patency period of the stent and preventing secondary infection of pseudocysts. In this study, we aim to evaluate the effect of the stent on the drainage of pancreatic pseudocyst.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Pseudocyst

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enteral-extended Anti-reflux Stents Group

Patients are going to implant enteral-extended anti-reflux stents

Group Type EXPERIMENTAL

Plant enteral-extended anti-reflux stents

Intervention Type COMBINATION_PRODUCT

Plant enteral-extended anti-reflux stents in EUS-guided drainage of pancreatic pseudocysts

Traditional Stents Group

Patients are going to implant traditional stents

Group Type ACTIVE_COMPARATOR

Plant traditional stents

Intervention Type COMBINATION_PRODUCT

Plant traditional stents in EUS-guided drainage of pancreatic pseudocysts

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plant enteral-extended anti-reflux stents

Plant enteral-extended anti-reflux stents in EUS-guided drainage of pancreatic pseudocysts

Intervention Type COMBINATION_PRODUCT

Plant traditional stents

Plant traditional stents in EUS-guided drainage of pancreatic pseudocysts

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pancreatic pseudocyst by a variety of causes, including acute pancreatitis, chronic pancreatitis, drug-induced pancreatitis
* Pseudocyst compressed gastrointestinal or bile duct and causes obstruction symptoms or causes other symptoms
* Diameter of pseudocyst \>6 cm with no compression symptoms, but progressively increases and is failed to conservatively treat

Exclusion Criteria

* Wall-off necrosis with liquidation mimics pseudocyst
* Pseudocyst formation ≤8 weeks, cyst wall is immature
* Cannot puncture by EUS-guided approach for any reason
* Patients with serious cardiovascular or cerebrovascular diseases or other diseases which are not fitted to anaesthetize
* Severe coagulopathy or thrombocytopenia

Minimum Eligible Age

12 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No